Gilead Sciences

Open: 77.22 Close: 76.65 Change: -0.57

Our AI found some flaws in Gilead Sciences Company Inc Stock.

The game is changing. There is a new strategy to evaluate Gilead Sciences fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Gilead Sciences are: Sciences, Gilead, company, stock, share, year, Inc, …

Concept Map

Semantic Network

Stock Summary

Gilead Sciences, Inc. discovers, develops, and commercializes medicines in the areas of unmet medical need. The company provides Biktarvy, Genvoya, Descovy, Descogna, Odefsey,.

Today's Summary

Gilead Sciences Inc. stock outperforms competitors on strong trading day - marketwatch.com. gilead sciences inc. stock out outperforms rivals on strong market day. Gileades has a rich and promising pipeline - especially in oncology.

Today's News

Gilead Sciences Inc. stock outperforms competitors on strong trading day - marketwatch.com. gilead sciences inc. stock out outperforms rivals on strong market day. Gilead Sciences is still deeply undervalued, which should lead to higher stock prices in the coming quarters. The company is still caught in a sideway range between $60 and $90 in which it has been in since 2016. Gilead Sciences has an annualized $3 billion run-rate and is expecting the oncology portfolio to contribute about 1/3 of total revenue. In the last few years, it was especially Biktarvy driving growth for Gileads. In theory, Gileades has a rich and promising pipeline - especially in oncologics. Robert W. Baird Sticks to Their Hold Rating for Gilead Sciences (GILD) InvestorPlace 8d GILD Stock Alert: FDA Approves Gileads Veklury Covid-19 Treatment. Gilead Sciences accounts for approximately 1.5% of Letko Brosseau & Associates investment portfolio. The company is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. Gilead Sciences, Inc. GILD is a strong Buy, according to Leerink Partners and Piper Sandler. The current share price is $76.49. Over the next 52 weeks, the company has historically risen by 29.5%. Gilead Sciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences. Analysts estimate an earnings decrease this quarter of $0.48 per share, an increase next quarter of$0.16 per share and a decrease this year. CFO Andrew D. Dickinson sold 5,000 shares of Gilead Sciences stock in a transaction dated Thursday, July 20th. Arrowstreet Capital Limited Partnership grew its holdings in shares of. GileAD Sciences, Inc, a biopharmaceutical company, discovers, develops and commercializes medicines in areas of unmet medical need. Gilead Sciences is a research-based biopharmaceutical company. This year marks the fifth anniversary of the Gileade COMPASS Initiative, a 10-year, more than $100 million commitment to addressing the HIV epidemic in the Southern United States.

Stock Profile

"Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Merck & Co, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; and Merck & Co, Inc. The company was incorporated in 1987 and is headquartered in Foster City, California."

Keywords

How much time have you spent trying to decide whether investing in Gilead Sciences? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Gilead Sciences are: Sciences, Gilead, company, stock, share, year, Inc, and the most common words in the summary are: gilead, science, job, stock, inc, company, market, . One of the sentences in the summary was: stock outperforms competitors on strong trading day - marketwatch.com. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #gilead #science #job #stock #inc #company #market.